VEGFA and neoplasm: It stimulates the tumor production of bone-active factors (PTHrP, IL-11, ET-1) and prometastatic factors (VEGF, CXCR4, CTGF, MMPs), which disrupt normal bone remodeling and promote invasion, angiogenesis, and homing of tumor cells to bone [9].